| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,243 |
2,058 |
$325K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,297 |
2,556 |
$222K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
926 |
816 |
$40K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,322 |
563 |
$31K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
462 |
140 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
743 |
300 |
$11K |
| J1756 |
Injection, iron sucrose, 1 mg |
256 |
56 |
$10K |
| 99215 |
Prolong outpt/office vis |
72 |
63 |
$7K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
182 |
83 |
$5K |
| 96415 |
|
141 |
56 |
$4K |
| 96367 |
|
221 |
121 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
372 |
186 |
$2K |
| 96417 |
|
47 |
25 |
$2K |
| J3490 |
Unclassified drugs |
44 |
12 |
$2K |
| J1453 |
Injection, fosaprepitant, 1 mg |
103 |
56 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
575 |
222 |
$387.79 |
| 0012A |
|
16 |
14 |
$280.00 |
| 0011A |
|
15 |
13 |
$240.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
50 |
24 |
$20.15 |
| 91301 |
|
30 |
28 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
15 |
12 |
$0.00 |